|
|
|
|
| The debate rages on. While the automation that enables continuous processing gets a lot of hype, there are plenty of dyed-in-the-wool biopharma pros who contend that process optimization and intensification yield comparable benefits, without requiring the capital-intensive process overhaul that continuous demands. Join Bioprocess Online Live for a virtual deep dive into the scalability, sustainability, and capital implications of the continuous-versus-optimized debate. Registration is free thanks to the support of Cytiva. |
|
|
|
|
By Tyler Menichiello, contributing editor | Continuous manufacturing was a hot topic of conversation at this year's BPI West. AstraZeneca's Ken Lee, Ph.D., weighs in during an exclusive interview with Bioprocess Online. | |
|
|
|
|
|
|
|
| Cell Based Potency Assays: De-Risk Your Path With An Experienced CDMO | Article | By Danny Rooney, FUJIFILM Diosynth Biotechnologies | Thorough characterization is key to unlocking the potential of antibody-based therapeutics. Leveraging a CDMO's extensive capabilities and expertise can allow you to navigate the biopharmaceutical development landscape. |
|
|
|
|
|
|
|
|
Connect With Bioprocess Online: |
|
|
|